Annual Total Liabilities
$2.60 M
-$34.85 M-93.07%
December 31, 2023
Summary
- As of February 8, 2025, CRVO annual total liabilities is $2.60 million, with the most recent change of -$34.85 million (-93.07%) on December 31, 2023.
- During the last 3 years, CRVO annual total liabilities has fallen by -$319.70 thousand (-10.97%).
- CRVO annual total liabilities is now -93.07% below its all-time high of $37.44 million, reached on December 31, 2022.
Performance
CRVO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.25 M
+$32.70 K+1.02%
September 30, 2024
Summary
- As of February 8, 2025, CRVO quarterly total liabilities is $3.25 million, with the most recent change of +$32.70 thousand (+1.02%) on September 30, 2024.
- Over the past year, CRVO quarterly total liabilities has increased by +$585.30 thousand (+21.99%).
- CRVO quarterly total liabilities is now -94.15% below its all-time high of $55.46 million, reached on March 1, 2017.
Performance
CRVO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CRVO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.1% | +22.0% |
| 3 y3 years | -11.0% | +22.0% |
| 5 y5 years | +0.2% | +22.0% |
CRVO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.1% | at low | -91.3% | +121.6% |
| 5 y | 5-year | -93.1% | at low | -91.3% | +121.6% |
| alltime | all time | -93.1% | +2635.2% | -94.2% | +2170.2% |
CervoMed Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.25 M(+1.0%) |
| Jun 2024 | - | $3.21 M(+20.8%) |
| Mar 2024 | - | $2.66 M(+2.5%) |
| Dec 2023 | $2.60 M(-93.1%) | $2.60 M(+5.4%) |
| Sep 2023 | - | $2.46 M(+68.2%) |
| Jun 2023 | - | $1.47 M(-31.1%) |
| Mar 2023 | - | $2.13 M(-94.3%) |
| Dec 2022 | $37.44 M(+1178.9%) | - |
| Dec 2022 | - | $37.44 M(+1549.0%) |
| Sep 2022 | - | $2.27 M(-9.7%) |
| Jun 2022 | - | $2.52 M(-14.9%) |
| Mar 2022 | - | $2.96 M(+1.0%) |
| Dec 2021 | $2.93 M(+0.4%) | $2.93 M(+6.5%) |
| Sep 2021 | - | $2.75 M(+8.0%) |
| Jun 2021 | - | $2.54 M(-0.8%) |
| Mar 2021 | - | $2.57 M(-12.0%) |
| Dec 2020 | $2.92 M(-26.7%) | $2.92 M(-8.7%) |
| Sep 2020 | - | $3.19 M(+2.4%) |
| Jun 2020 | - | $3.12 M(-1.2%) |
| Mar 2020 | - | $3.16 M(-20.6%) |
| Dec 2019 | $3.98 M(+53.5%) | $3.98 M(+48.5%) |
| Sep 2019 | - | $2.68 M(-2.7%) |
| Jun 2019 | - | $2.75 M(-9.3%) |
| Mar 2019 | - | $3.03 M(+17.1%) |
| Dec 2018 | $2.59 M(-47.3%) | $2.59 M(-3.6%) |
| Sep 2018 | - | $2.69 M(+1.6%) |
| Jun 2018 | - | $2.64 M(-27.5%) |
| Mar 2018 | - | $3.65 M(-25.8%) |
| Dec 2017 | $4.92 M(-40.8%) | $4.92 M(-77.6%) |
| Sep 2017 | - | $21.97 M(-32.9%) |
| Jun 2017 | - | $32.74 M(-41.0%) |
| Mar 2017 | - | $55.46 M(+568.2%) |
| Dec 2016 | $8.30 M(+258.0%) | $8.30 M(+9.8%) |
| Sep 2016 | - | $7.56 M(+28.3%) |
| Jun 2016 | - | $5.89 M(-7.0%) |
| Mar 2016 | - | $6.33 M(+173.2%) |
| Dec 2015 | $2.32 M | $2.32 M(-46.2%) |
| Sep 2015 | - | $4.31 M(-11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $4.84 M(+10.9%) |
| Mar 2015 | - | $4.37 M(-5.3%) |
| Dec 2014 | $4.61 M(-61.2%) | $4.61 M(-40.5%) |
| Sep 2014 | - | $7.75 M(-16.1%) |
| Jun 2014 | - | $9.23 M(-35.1%) |
| Mar 2014 | - | $14.23 M(+19.8%) |
| Dec 2013 | $11.88 M(-43.0%) | $11.88 M(+24.1%) |
| Sep 2013 | - | $9.57 M(+9.2%) |
| Jun 2013 | - | $8.77 M(-60.0%) |
| Mar 2013 | - | $21.92 M(+5.1%) |
| Dec 2012 | $20.85 M(+6.0%) | $20.85 M(+108.9%) |
| Sep 2012 | - | $9.98 M(+13.7%) |
| Jun 2012 | - | $8.78 M(+52.2%) |
| Mar 2012 | - | $5.77 M(-70.7%) |
| Dec 2011 | $19.68 M(+254.2%) | $19.68 M(+396.5%) |
| Sep 2011 | - | $3.96 M(+3.9%) |
| Jun 2011 | - | $3.81 M(-38.2%) |
| Mar 2011 | - | $6.17 M(+11.1%) |
| Dec 2010 | $5.56 M(+46.6%) | $5.56 M(+21.0%) |
| Sep 2010 | - | $4.59 M(+4.6%) |
| Jun 2010 | - | $4.39 M(+6.9%) |
| Mar 2010 | - | $4.10 M(+8.3%) |
| Dec 2009 | $3.79 M(-23.0%) | $3.79 M(-28.2%) |
| Sep 2009 | - | $5.28 M(+3.8%) |
| Jun 2009 | - | $5.08 M(+0.1%) |
| Mar 2009 | - | $5.08 M(+3.1%) |
| Dec 2008 | $4.92 M(-35.3%) | $4.92 M(-35.5%) |
| Sep 2008 | - | $7.63 M(+2.1%) |
| Jun 2008 | - | $7.48 M(+0.7%) |
| Mar 2008 | - | $7.43 M(-2.4%) |
| Dec 2007 | $7.61 M(+5221.0%) | $7.61 M(+3635.4%) |
| Sep 2007 | - | $203.70 K(+6.6%) |
| Jun 2007 | - | $191.00 K(+28.9%) |
| Mar 2007 | - | $148.20 K(+3.6%) |
| Dec 2006 | $143.00 K(+50.7%) | $143.00 K |
| Dec 2005 | $94.90 K(-99.5%) | - |
| Dec 1999 | $19.41 M(+49.3%) | - |
| Dec 1998 | $13.00 M | - |
FAQ
- What is CervoMed annual total liabilities?
- What is the all time high annual total liabilities for CervoMed?
- What is CervoMed annual total liabilities year-on-year change?
- What is CervoMed quarterly total liabilities?
- What is the all time high quarterly total liabilities for CervoMed?
- What is CervoMed quarterly total liabilities year-on-year change?
What is CervoMed annual total liabilities?
The current annual total liabilities of CRVO is $2.60 M
What is the all time high annual total liabilities for CervoMed?
CervoMed all-time high annual total liabilities is $37.44 M
What is CervoMed annual total liabilities year-on-year change?
Over the past year, CRVO annual total liabilities has changed by -$34.85 M (-93.07%)
What is CervoMed quarterly total liabilities?
The current quarterly total liabilities of CRVO is $3.25 M
What is the all time high quarterly total liabilities for CervoMed?
CervoMed all-time high quarterly total liabilities is $55.46 M
What is CervoMed quarterly total liabilities year-on-year change?
Over the past year, CRVO quarterly total liabilities has changed by +$585.30 K (+21.99%)